Sanat Chattopadhyay Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 weeks, 2 days ago
Sanat Chattopadhyay has an estimated net worth of at least $44.0 million*, as of March 26, 2025. They own shares of MRK stock. They have sold 342,960 shares of MRK stock since 2021, for an estimated $37.0 million.
Sanat Chattopadhyay $MRK SEC Form 4 Insider Trading
Sanat Chattopadhyay has filed a total of 9 insider trades in $MRK since 2021. Their most recent trade was a sale of 67,892 shares, made on Apr 13, 2023. Their largest trade was a sale of 100,292 shares, made on Oct 28, 2022. We estimate that they now own shares of $MRK, worth an estimated $7.0 million.
Insider Trading at $MRK
There have been a total of 91 insider trades reported at $MRK since 2021, with 18,241 shares purchased and 5.1 million shares sold. The most active insider traders in $MRK stock have been Kenneth C Frazier, Steven Mizell, and Joseph Romanelli. The most recent trade was a sale of 6,000 shares reported by David Michael Williams (EVP,Chief Info&Digital Officer), made on Feb 13, 2025.
History of Insider Stock Trades by Sanat Chattopadhyay
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
MRK
|
Sale | 67,892 | Apr 13, 2023 | April 14, 2023, 4:34 p.m. |
|
MRK
|
Sale | 66,163 | Apr 13, 2023 | April 14, 2023, 4:34 p.m. |
|
MRK
|
Sale | 4,538 | Jan 09, 2023 | Jan. 11, 2023, 5:22 p.m. |
|
MRK
|
Sale | 38,216 | Jan 09, 2023 | Jan. 11, 2023, 5:22 p.m. |
|
MRK
|
Sale | 1,702 | Jan 09, 2023 | Jan. 11, 2023, 5:22 p.m. |
|
MRK
|
Sale | 3,940 | Jan 09, 2023 | Jan. 11, 2023, 5:22 p.m. |
|
MRK
|
Sale | 35,598 | Jan 09, 2023 | Jan. 11, 2023, 5:22 p.m. |
|
MRK
|
Sale | 100,292 | Oct 28, 2022 | Nov. 1, 2022, 5:07 p.m. |
|
MRK
|
Sale | 24,619 | Oct 29, 2021 | Nov. 1, 2021, 8 p.m. |
$MRK Executives and Stock Owners with Insider Trades
-
Kenneth C Frazier, Executive Chair
-
Steven Mizell, EVP, Chief HR Officer
-
Joseph Romanelli, President, Human Health Int?l
-
Sanat Chattopadhyay, Exe V-P & Pres. MMD
-
Richard R. Deluca, EVP&Pres, Merck Animal Heallth
-
Jennifer Zachary, EVP, General Counsel
-
Johannes Jacobus Oosthuizen, President, U.S. Market
-
Robert M Davis, Chairman, CEO & President
-
Rita A Karachun, Sr. VP Fince-Global Controller
-
Robert M Davis, CEO & President
-
Caroline Litchfield, EVP & CFO
-
David Michael Williams, EVP,Chief Info&Digital Officer
-
Cristal N Downing, Chief Comm. & Public Afrs Ofcr
-
Dean Y Li, Executive VP & President, MRL
-
Frank Clyburn, EVP & Pres ? Human Health
-
Julie L. Gerberding, EVP, Chief Patient Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.